Get the app!
Back to Companies

Y-mAbs Therapeutics, Inc.

YMABCIK: 0001722964

Y-mAbs Therapeutics, Inc. (YMAB) shows 11 recent insider filings from 11 insiders, with no open-market buying or selling. Wedell-Wedellsborg Johan is the most active by dollar volume, and the single largest transaction was $41.8M by Wedell-Wedellsborg Johan. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$147.1M
Purchases
$0
Sales
$0
Unique Insiders
11

Recent Insider Trades

11 loaded
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
Wilms JorisInsiderDisposed$4.2M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
Rossi Michael JInsiderDisposed$8.0M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
LaRocca JohnInsiderDisposed$1.7M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
GILL DAVID NInsiderDisposed$2.3M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
HEALY JAMESInsiderDisposed$21.1M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
PFREUNDSCHUH PETER P.InsiderDisposed$2.5M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
Wedell-Wedellsborg JohanInsiderDisposed$41.8M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
TYAGI ASHUInsiderDisposed$3.6M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
Gad ThomasInsiderDisposed$21.9M
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
Gentilcore Douglas JInsiderDisposed$878.4K
Sep 18YMAB
Y-mAbs Therapeutics, Inc.
WG Biotech ApSInsiderOther$39.2M

11 filings